- Chart
- Upturn Summary
- Highlights
- Valuation
Upturn AI Summary - About
Heartflow, Inc. Common Stock(HTFL)
Advisory History & Simulated Performance *
*as per simulation (see disclosures)- ALL
- 1Y
- 1M
- 1W
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- PASS (Skip)
Advisory Performance History (Simulated)
Upturn Advisory & Investor View for HTFL
11/13/2026: HTFL (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Heartflow, Inc. is a commercial-stage medical technology company that provides AI-driven, non-invasive software solutions for diagnosing and managing coronary artery disease. The company's primary business strength lies in its proprietary Heartflow One platform, which leverages computational fluid dynamics and robust clinical validation to reduce unnecessary invasive procedures. Its main growth opportunity centers on expanding insurance reimbursement and scaling hospital adoption of its advanced diagnostic tools globally. Key risks include ongoing net losses, valuation sensitivity, and execution challenges in hospital sales cycles. HTFL is best suited for growth-oriented investors willing to monitor commercial execution, clinical trial outcomes, and ongoing reimbursement progress.
How to Read the Upturn Advisory
The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.
Company fundamentals, valuation, risks, and news provide supporting context about the business.
Investor Fit
| Investor style | Fit | Why |
|---|---|---|
| Growth investor | Strong fit | The company features rapid, high-double-digit revenue growth and an expanding total addressable market in healthcare AI. |
| Momentum investor | Strong fit while signal remains positive | Stock price momentum and frequent positive clinical catalysts attract active market participants. |
| Value investor | Weak fit | Heartflow remains unprofitable on a GAAP basis and trades at high growth-adjusted multiples. |
| Dividend investor | Weak fit | The company pays no dividends and reinvests all cash flows into commercial scaling. |
| Low-risk investor | Weak fit | High share price volatility and ongoing net losses create elevated risk exposure. |
Risk Profile
| Risk factor | Level | Why it matters |
|---|---|---|
| Price volatility | High | The stock experiences significant price swings typical of commercial-stage medical technology equities. |
| Valuation risk | Medium / high | High expectations are baked into the valuation, leaving little room for operational execution misses. |
| Competition risk (AI and medical device competition) | Medium | The company faces ongoing competition from established cardiovascular device makers and emerging AI diagnostics. |
| Business quality | Strong | Heartflow possesses strong proprietary technology and robust clinical validation supporting its SaaS platform. |
| Dividend income | Low / none | No dividend is paid, making it unsuitable for income-seeking investors. |
| Execution risk | Medium / high | Future success depends heavily on scaling hospital sales channels and securing broader global reimbursement. |
Key Highlights
Company Size Mid-Cap Stock | Market Capitalization 4.26B USD | Price to earnings Ratio 72.33 | 1Y Target Price 63.12 |
Price to earnings Ratio 72.33 | 1Y Target Price 63.12 | ||
Volume (30-day avg) 1.8M shares | Beta - | 52 Weeks Range 20.13 - 60.66 | Updated Date 11/15/2026 |
52 Weeks Range 20.13 - 60.66 | Updated Date 11/15/2026 | ||
Dividends yield (FY) - | Basic EPS (TTM) 0.67 |
Sector & Industry Intelligence
Sector
Healthcare
Bullish- Sentiment
- Strong Bullish
- Momentum
- Momentum Steady
- BUY participation
- 62.6%
- Active BUY / eligible
- 72 / 115
- 30-Day BUY Count Change
- +35
- Market state
- Strong Bullish
The number of qualifying BUY stocks has remained relatively stable.
Industry
Health Information Services
- BUY participation
- 100.0%
- Active BUY / eligible
- 4 / 4
- 30-Day BUY Count Change
- +2
Eligible universe: 4 stocks.
Sector signal summarizes BUY breadth conditions for the sector. It does not override this stock’s BUY, SELL, or PASS advisory.
Price Behavior

Strong Uptrend
The stock has maintained a strong upward price trend across the last three quarters.

Extreme Price Shocks
The stock has experienced exceptionally large and disruptive price movements during the period.
Analysis of Past Performance
Type Stock | Historic Profit -29.98% | Avg. Invested days 32 | Today’s Advisory WEAK BUY |
Upturn Advisory Rating ![]() | Upturn Advisory Performance | Stock Returns Performance |
Upturn Scorecard
Upturn Star Rating 
Company Fundamentals 
Financial Health Rating 
Growth Momentum Score 
Ownership 
Top 5 Institutional Investors
Unit Economics (Per $1K Revenue) 
Economic Dimensions
Quantitative Style Profile 
Style Classification
Quality Focused
How Company Makes Money
| Business area | What it includes | Retail investor read |
|---|---|---|
| Heartflow One Software Platform Services | Per-test analysis fees and service agreements for FFRct, Roadmap, and Plaque Analysis software utilized by hospitals and imaging centers. | The company generates core revenue each time a medical facility uses its cloud-based software to analyze a patient's cardiac CT scan. |
| Global Commercial Operations | Direct sales and distribution across domestic and international healthcare markets. | International expansion provides secondary revenue streams alongside its core U.S. hospital customer base. |
Analyzing Revenue: Products, Geography and Growth
Revenue by Geography
Geography revenue - Year on Year
Valuation
Trailing PE 72.33 | Forward PE - | Enterprise Value 4.12B | Price to Sales(TTM) 17.85 |
Enterprise Value 4.12B | Price to Sales(TTM) 17.85 | ||
Enterprise Value to Revenue 17.24 | Enterprise Value to EBITDA - | Shares Outstanding 87.89M | Shares Floating 68.01M |
Shares Outstanding 87.89M | Shares Floating 68.01M | ||
Percent Insiders 5.7 | Percent Institutions 99.65 |
Financial Metrics
🧭 Investment Snapshot
Total Revenue (Scale)
Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.
Net Income (Profit)
Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.
Free Cash Flow (Cash Strength)
Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.
📈 Growth & Strength
Operating Income (Core Profit)
Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.
EBITDA (Cash Earnings)
Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.
Gross Profit (Unit Profitability)
Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.
🛡️ Financial Safety
Cash (Liquidity Buffer)
Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.
Total Debt (Leverage Risk)
Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.
Net Working Capital (Short-Term Health)
Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.
🧱 Balance Sheet Strength
Stockholder Equity (Net Worth)
Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.
Total Assets (Asset Base)
The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.
Income Before Tax (Pre-Tax Earnings)
Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.
⚙️ Cost & Drag Factors
Cost of Revenue (Production Cost)
Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.
Total Operating Expenses (Operating Cost)
Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.
Income Tax Expense (Tax Drag)
Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
All company names, trademarks, logos, and brands are the property of their respective owners and are used for identification and informational purposes only. Use of these names, trademarks, and logos does not imply endorsement by their respective owners.

